Skip to content
2000
Volume 13, Issue 3
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

A series of symmetrical Schiff base derivatives (L1-L7) were designed by a one-pot condensation reaction of various aldehyde/ketone compounds with hydrazine under mild conditions (room temperature, 3 days), using ether as solvent and acetic acid as catalyst. The target products were characterized and analysed by 1H and 13C NMR, FT-IR and liquid chromatography mass spectrometry (LC/MS). Our research focuses on the identification of synthetically chemotherapeutic substances able to inhibit, delay, or reverse the process of carcinogenesis in several stages. The target compounds presenting two regions for SAR evaluation were screened for their activity toward MDA-MB-241 breast cancer cell proliferation for the first time. Compound (1E, 2E)-1,2-bis(1-(3-nitrophenyl)ethylidene) hydrazine (L6) showed significant inhibitory activity (IC50 = 7.08 μg/mL).

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180812999150812165510
2016-03-01
2025-06-12
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180812999150812165510
Loading

  • Article Type:
    Research Article
Keyword(s): antitumor activity; breast cancer; cell proliferation; heterocycles; nitro; Schiff bases
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test